Search research articles
Contact Us
Filters
Showing results (221-230 of 453) with videos related to
Page
of 46
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2018
<i>MGMT</i> Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical Trials
Monika E Hegi, Els Genbrugge, Thierry Gorlia, et al.
Neuro-Oncology
|
May 7, 2013
Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677
Eva-Maria Ratai, Zheng Zhang, Bradley S Snyder, et al.
Neuro-Oncology
|
March 12, 2014
Pregnancy and glial brain tumors
Shlomit Yust-Katz, John F de Groot, Diane Liu, et al.
Cancer Research
|
September 7, 2019
Mitochondrial NIX Promotes Tumor Survival in the Hypoxic Niche of Glioblastoma
Jinkyu Jung, Ying Zhang, Orieta Celiku, et al.
Frontiers in Oncology
|
November 10, 2022
Metabolic biomarkers of radiotherapy response in plasma and tissue of an IDH1 mutant astrocytoma mouse model
Victor Ruiz-Rodado, Tyrone Dowdy, Adrian Lita, et al.
NPJ Aging and Mechanisms of Disease
|
May 5, 2021
Impact of age on the circadian visual system and the sleep-wake cycle in mus musculus
Dorela D Shuboni-Mulligan, Demarrius L Young, Julianie De La Cruz Minyety, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 20, 2010
Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system
Victor A Levin, Luc Bidaut, Ping Hou, et al.
Molecular Cancer Therapeutics
|
June 4, 2025
Beyond the Promoter: Total MGMT Gene Methylation Modulates Response to DNA Alkylating Agents in Glioma
Nicole J Briceno, Jinkyu Jung, Aiguo Li, et al.
Journal of Neuro-Oncology
|
March 10, 2009
Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma
Morris D Groves, Kenneth R Hess, Vinay K Puduvalli, et al.
Brain Pathology (Zurich, Switzerland)
|
June 6, 2020
cIMPACT-NOW update 7: advancing the molecular classification of ependymal tumors
David W Ellison, Kenneth D Aldape, David Capper, et al.
Page
of 46
Search research articles
Search
Showing results (221-230 of 453) with videos related to
Sort By:
Page
of 46
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2018
<i>MGMT</i> Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical Trials
Monika E Hegi, Els Genbrugge, Thierry Gorlia, et al.
Neuro-Oncology
|
May 7, 2013
Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677
Eva-Maria Ratai, Zheng Zhang, Bradley S Snyder, et al.
Neuro-Oncology
|
March 12, 2014
Pregnancy and glial brain tumors
Shlomit Yust-Katz, John F de Groot, Diane Liu, et al.
Cancer Research
|
September 7, 2019
Mitochondrial NIX Promotes Tumor Survival in the Hypoxic Niche of Glioblastoma
Jinkyu Jung, Ying Zhang, Orieta Celiku, et al.
Frontiers in Oncology
|
November 10, 2022
Metabolic biomarkers of radiotherapy response in plasma and tissue of an IDH1 mutant astrocytoma mouse model
Victor Ruiz-Rodado, Tyrone Dowdy, Adrian Lita, et al.
NPJ Aging and Mechanisms of Disease
|
May 5, 2021
Impact of age on the circadian visual system and the sleep-wake cycle in mus musculus
Dorela D Shuboni-Mulligan, Demarrius L Young, Julianie De La Cruz Minyety, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 20, 2010
Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system
Victor A Levin, Luc Bidaut, Ping Hou, et al.
Molecular Cancer Therapeutics
|
June 4, 2025
Beyond the Promoter: Total MGMT Gene Methylation Modulates Response to DNA Alkylating Agents in Glioma
Nicole J Briceno, Jinkyu Jung, Aiguo Li, et al.
Journal of Neuro-Oncology
|
March 10, 2009
Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma
Morris D Groves, Kenneth R Hess, Vinay K Puduvalli, et al.
Brain Pathology (Zurich, Switzerland)
|
June 6, 2020
cIMPACT-NOW update 7: advancing the molecular classification of ependymal tumors
David W Ellison, Kenneth D Aldape, David Capper, et al.
Page
of 46